RUMI SCIENTIFIC, INC.
New York, NY · Biotech · Private
Mini-lung organotypic platform for modeling respiratory virus infection and screening therapeutics
- Grants
- $2.6M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · STTR Phase I: A Machine Learning Toolbox to Identify Therapeutics for Rare Genetic Disorders from Phenotypic Screens on Micropattern-Based Organoids | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Discovery of new therapeutics for Huntingtons Disease through successive reversal of phenotypic signatures | $149,968 | |
| Federal grant | Department of Health and Human Services · Phase I · Self-organizing synthetic human lungs on microchips to fight infection by RSV | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids | $1,006,032 | |
| Federal grant | Department of Health and Human Services · Phase II · An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids | $873,768 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1572 | Coultreon Biopharma | — | — |
| 1573 | NANORED LLC | — | — |
| 1574 | GENELUX Corp | — | $24M |
| 1575 | RUMI SCIENTIFIC, INC. | — | — |
| 1576 | Max Biopharma, Inc. | — | — |
| 1577 | Neurocarrus Inc. | — | — |
| 1578 | ANOVAC, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.